Combo Drug Therapy Offers Promise to Treat Meth Use Disorder

Jan. 13, 2021, 10:01 PM

A combination of anti-addiction drugs for opioids and smoking may offer the first pharmaceutical therapy to treat methamphetamine use disorder, an understudied condition that’s linked to increasing overdose deaths.

A clinical trial testing such a therapy found participants in the treatment group had a significantly better response than those in the placebo arm, according to findings published Wednesday in the New England Journal of Medicine.

The trial shows the largest effects to date for a pharmaceutical intervention to address meth use disorder, Nora D. Volkow, director of the National Institute on Drug Abuse at the National Institutes of Health, ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.